Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2025-01-07
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children
NCT05111431
Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children
NCT01065701
A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children
NCT04200235
Pharmacological Characteristics of Intranasally Given Dexmedetomidine in Paediatric Patients
NCT02955732
Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children
NCT02836431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DR1 group
Dexmedetomidine injection 3μg/kg+ remimazolam 0.5mg/kg group
Dexmedetomidine injection
Dexmedetomidine injection 3μg/kg
Remimazolam
remimazolam 0.5mg / kg
DR2 group
Dexmedetomidine nasal spray 3μg/kg+ remimazolam 0.5mg/kg group
Remimazolam
remimazolam 0.5mg / kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine injection
Dexmedetomidine injection 3μg/kg
Remimazolam
remimazolam 0.5mg / kg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-II;
* sign the informed consent.
Exclusion Criteria
* abnormal liver and kidney function;
* severe dehydration, severe malnutrition, hypoproteinemia or anaemia Hb \<10 g/dl;
* children with neurological disease;
* history of allergy to the study drug;
* recent participation in other clinical studies.
2 Years
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
aijun xu
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
pu zhou, Dr.
Role: STUDY_CHAIR
Tongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tongji hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEXS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.